Medium 5.4Published Jun 24, 2026

CVE-2026-52816Gogs is an open source self-hosted Git service.

Updated under an hour ago (2026-10-19 06:50 UTC)

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stack

Free account, 1 product

Exploited in the last 30 days

Gogs is an open source self-hosted Git service. Prior to 0.14.3, the Jupyter Notebook (ipynb) sanitizer endpoint at POST /-/api/sanitize_ipynb allows arbitrary data: URIs without proper restrictions, potentially leading to Cross-Site Scripting (XSS). The endpoint uses bluemonday.UGCPolicy() with p.AllowURLSchemes("data") which permits all data URI schemes including data:text/html, enabling attackers to inject malicious HTML/JavaScript. Additionally, the endpoint has no authentication middleware, allowing any registered user to exploit this vulnerability. This vulnerability is fixed in 0.14.3.

CVSS: 5.4 MEDIUM (v4.0, NVD)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:N/SC:H/SI:H/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Weakness (CWE): CWE-80
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: Not given
NVD analysis: Deferred
Record last updated: Jun 25, 2026
First seen by InfoSec Signals: Oct 9, 2026

Affected products

No affected products are listed yet.

References

https://github.com/gogs/gogs/commit/dd1bd9837aa196b3ed3a8ee21e5727b5d7a986a3
https://github.com/gogs/gogs/pull/8326
https://github.com/gogs/gogs/releases/tag/v0.14.3
https://github.com/gogs/gogs/security/advisories/GHSA-3w28-36p9-w929

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.